The transition from research to regulated manufacturing requires careful planning. A startup needs a QMS that reflects its current activities while preparing for future expansion.
Stage-appropriate quality is ultimately about proportionality, scientific discipline, and long-term sustainability.
Pharmaceutical quality systems are directly connected to long-term business sustainability.
In GxP-regulated environments, the ability to see clearly is a prerequisite for effective action. Without sufficient visibility, even well-designed systems and highly capable teams are vulnerable to hidden risks. These risks, if left unaddressed, will eventually surface, often at the most inopportune time.